Trump’s decision and shares of pharmaceutical companies fall ill, why big fall

Last Updated: May 12, 2025, 11:00 ISTPHARMA Stock Down: Shares of Indian pharma companies see a big decline on Monday morning. The impact of US President Donald Trump’s decision to reduce the price of drugs is visible on the Indian market. Many companies … and Padhendonald Trump have ordered to reduce the prices of medicines in America. Indian pharma stocks declined by highlightest’s decision, more than 2% declines in Indian pharma index, Indian pharma exports at $ 9 billion. Although the bumper bounce is seen in the Indian stock market today, but there is also a sector whose stocks of almost all companies are trading under pressure today. The most emphasis of the stock market investors today is with 2 sectors. On the one hand there are stocks of defense companies which are showing a tremendous boom and on the other side there are pharma companies where almost all stocks are seen to fall. The reason for this decline in shares of pharma companies has also come from across the seven seas. After a decision by US President Donald Trump, his stocks collapsed as soon as their stocks opened today. What has been stamped by President Donald Trump on the most important decision in American history, its direct impact has been shown on Indian pharmaceutical companies. On Monday morning, the Indian stock market showed a sharp jump and the Sensex reached trading at a jump of 2,000 points at one time, but in this fast, shares of pharmaceutical companies are seen in the ICU. Seeing their sick condition, the investors also considered it necessary to distance and the stores of some companies came down by 7 per cent due to the selling selling. Where the declining pharma index is showing more than 2 percent decline in the pharma index this morning. Pharma Index opened at 20,949.70 and started trading at 20,576.05 soon. Aurobindo Pharma shares also saw more than 2 percent decline this morning and it was trading Rs 1,141.50. The shares of Sun Pharma are also seeing a decline of 3.87 percent this morning and its price has reached Rs 1,677.30. The shares of Biocon Company also saw a decline of 0.27 percent and the price of Rs 329 is being sold. Apart from this, stores of pharmaceutical companies like Suven Pharma, Lupin, Divis and Glenmark are seeing 1 to 3 percent decline. Also read – Share Market Live: 1947 points, Nifty beyond 600 points, what was the shares of defense as a rocket, Trump had approved a big decision on Sunday. Trump has said in his judgment that the prices of drugs in the US will be reduced by 30 to 80 percent due to immediate effects. He said that the prices of these drugs in America are much higher than other countries. Americans should also get the benefit of this cheap medicine. So we decide to reduce the prices of medicines by 80 percent. How much export of India will have an impact on the Indian pharmaceutical companies, how much it will have an impact on Indian pharmaceutical companies. In the financial 2023-24, the Indian pharma sector exported $ 9 billion (about 75 thousand crores) to the US. This is about 31 percent of the total exports of Indian companies. Not only this, 40 percent of the total generic medicines used in America are sent only from India. This is the reason that the decision of the US President is also going to be a bad effect on the Indian pharmaceutical industry. Pharmaceutical companies are afraid that this decision may reduce their earnings. Pramod Kumar Tiwari Pramod Kumar Tiwari likes to cover the stock market, investment tips, tax and personal finance. Explains complex subjects very easily. In newspapers, dozens of columns have also been written on personal finance. Journalist … Read more Pramod Kumar Tiwari likes to cover the stock market, investment tips, tax and personal finance. Explains complex subjects very easily. In newspapers, dozens of columns have also been written on personal finance. Journalists … Read more India’s latest news on News18 India Location: New Delhi, Delhihomebusiness Trump’s decision and shares of pharmaceutical companies fell ill, why the big decline

Source link